Pitsui M, Parker E, Aarons L, Rowland M. 1993.
‘Population pharmacokinetics and pharmacody-
namics of warfarin in healthy young adults’.Eur.
J. Pharm. Sci. 1 : 151.
Rane A, Wilkinson G, Shand D. 1977. ‘Prediction of
hepatic extraction fromin vitromeasurement of
intrinsic clearance’.J. Pharmacol. Exp. Ther. 200 :
420–424.
Ross EM. 1996. ‘Pharmacodynamics: mechanisms of
drug action and the relationship between drug con-
centration and effect’. InGoodman and Gilman’s
Pharmacological Basis of Therapeutics, 10th edn.
Pergamon: New York.
Rowley M, Kulagowski JJ, Walt AP,et al. 1997. ‘Effect
of plasma protein binding onin vivoactivity and
brain penetration of glycine/NMDA receptor
antagonists’.J. Med. Chem. 40 : 4053–4068.
Segre G. 1968. ‘Kinetics of interaction between drugs
and biological systems’.Il Farmaco 23 : 907.
Sharma A, Jusko WJ. 1997. ‘Characterization of four
basic models of indirect pharmacological responses’.
J. Pharmacokinet. Biopharm. 24 : 611–635.
Sheiner LB, Stanski DR, Vozeh S,et al. 1979. ‘Simul-
taneous modelling of pharmacokinetics and phar-
macodynamics: application toD-tubocurarine’.Clin.
Pharmacol. Ther. 25 : 358.
Shimada T, Yamazaki H, Minura M,et al. 1994. ‘Inter-
individual variations in human liver cytochrome
P450 enzymes involved in the oxidation of drugs,
carcinogens, and toxic chemicals: studies with liver
microsomes of 30 Japanese and 30 Caucasians’.J.
Pharmacol. Exp. Ther.270: 414–423.
Smith DA, Jones BC, Walker DK. 1996. ‘Design of
drugs involving the concepts and theories of drug
metabolism and pharmacokinetics’.Med. Res. Rev.
16 : 243–266.
Smolen VF. 1976. ‘Theoretical and computational basis
for drug bioavailability determinations using phar-
macological data. I. General considerations and
procedures’.J. Pharmacokinet. Biopharm. 4 : 337.
Smolen VF. 1971. ‘Quantitative determination of
drug bioavailability and biokinetic behavior from
pharmacological data for ophthalmic and oral
administration of a mydriatic drug’.J. Pharm. Sci.
60 : 354.
Wagner JG. 1968. ‘Kinetics of pharmacological
response. I. Proposed relationships between
response and drug concentration in the intact animal
and man’.J. Theor. Biol. 20 : 173.
Welling PG, Tse FLS (eds). 1995.Pharmacokinetics:
Regulatory–Industrial–Academic Perspectives, 2nd
edn. Marcel Dekker: New York.
Wilkinson GR. 1987. ‘Clearance approaches in phar-
macology’.Pharmacol. Rev. 39 : 1–47.
Yee S. 1997. ‘In vitropermeability across Caco-2 cells
(colonic) can predictin vivo(small intestinal) abs-
orption in man – fact or myth’.Pharm. Res. 14 : 763–
766.100 CH8 PHASE I: THE FIRST OPPORTUNITY FOR EXTRAPOLATION FROM ANIMAL DATA